以ETF为例，三天内嘉实中证港股通创新药ETF、富国恒生港股通创新药及医疗保健ETF等5只基金涨幅 超过7%，华泰柏瑞恒生创新药ETF等其余13只产品涨超6%，还有多只跟踪A股的相关产品涨超5%。 拉长时间来看，2025年上半年A股和港股两地创新药板块联袂上涨，截至2025年三季度末尚有多只主动 权益产品位列"翻倍基"名单，但经历四季度的回撤后数量大减。据统计，去年四季度内，创新药主题基 金集体下跌，十余只港股创新药概念ETF回撤幅度超过20%。 因此，在医药板块，尤其是创新药领域在经历近期回调后，多名基金经理表示，当前估值已进入具有吸 引力的区间，今年或许是布局医药的好时机。 "创新药预计仍是2026年医药板块最重要的投资主线。"平安基金表示，当前板块经历近2～3个月调整 后，股价、市场预期与机构配置均已回到相对低位，投资安全边际显著提升。行业正面催化正在密集释 放，进入2026年一季度，以JPM大会为代表的行业盛会，叠加企业商业化及出海进展，将持续提供股价 催化剂。同时，海外流动性环境改善预期升温，美国降息前景强化，美股生物科技指数持续走强，映射 出全球创新药投融资与需求端有望逐步回暖。 但像去年上半年的 ...

步入2026年的3个交易日里，A股持续走强，在半导体、有色板块集体上涨的势头中，此前一度"沉寂"的创 新药板块也再度亮眼，其中港股创新药板块更为出色；此外叠加"脑机接口"的风潮，有公募认为此前沉寂 数年的医疗器械板块或也迎来投资机遇。 展望后市，"普涨"已不再是基金经理的共识，而具备业绩验证的优质个股或将走出持续性的独立行情；此外， 因具备更好的研发和盈利前景，出海能力也成为多名基金经理筛选公司的核心标准之一。 创新药板块回暖 以ETF为例，三天内嘉实中证港股通创新药ETF、富国恒生港股通创新药及医疗保健ETF等5只基金涨幅超过 7%，华泰柏瑞恒生创新药ETF等其余13只产品涨超6%，还有多只跟踪A股的相关产品涨超5%。 拉长时间来看，2025年上半年A股和港股两地创新药板块联袂上涨，截至2025年三季度末尚有多只主动权益产 品位列"翻倍基"名单，但经历四季度的回撤后数量大减。据统计，去年四季度内，创新药主题基金集体下跌， 十余只港股创新药概念ETF回撤幅度超过20%。 "脑机接口"或带火医疗器械 值得注意的是，近几个交易日内"脑机接口"概念异军突起，消息面上，马斯克在社交媒体表示，Neuralink预计 在 ...

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 步入2026年的3个交易日里，A股持续走强，在半导体、有色板块集体上涨的势头中，此前一度"沉 寂"的创新药板块也再度亮眼，其中港股创新药板块更为出色；此外叠加"脑机接口"的风潮，有公募认 为此前沉寂数年的医疗器械板块或也迎来投资机遇。 展望后市，"普涨"已不再是基金经理的共识，而具备业绩验证的优质个股或将走出持续性的独立行情； 此外，因具备更好的研发和盈利前景，出海能力也成为多名基金经理筛选公司的核心标准之一。 创新药板块回暖 因此，在医药板块，尤其是创新药领域在经历近期回调后，多名基金经理表示，当前估值已进入具有吸 引力的区间，今年或许是布局医药的好时机。 "创新药预计仍是2026年医药板块最重要的投资主线。"平安基金表示，当前板块经历近2~3个月调整 后，股价、市场预期与机构配置均已回到相对低位，投资安全边际显著提升。行业正面催化正在密集释 放，进入2026年一季度，以JPM大会为代表的行业盛会，叠加企业商业化及出海进展，将持续提供股价 催化剂。同时，海外流动性环境改善预期升温，美国降息前景强化，美股生物科技指数持续走强，映射 出全 ...

Core Insights - On September 17, the total net inflow of cross-border ETFs reached 1.679 billion yuan, with a cumulative net inflow of 18.097 billion yuan over the past five trading days [1][2] - A total of 40 cross-border ETFs experienced net inflows on the same day, with the E Fund CSI Hong Kong Stock Connect Internet ETF (513040) leading the inflow, increasing by 319 million shares and net inflow of 550 million yuan [1][3] - Conversely, 24 cross-border ETFs saw net outflows, with the Huatai-PineBridge Southbound Hang Seng Technology (QDII-ETF) (513130) having the largest outflow, decreasing by 300 million shares and a net outflow of 249 million yuan [1][4] Inflow Details - The E Fund CSI Hong Kong Stock Connect Internet ETF (513040) had a price increase of 3.35%, with a total of 2.092 billion yuan in the latest scale [3][5] - Other notable inflows included: - China Asset Management Hang Seng Biotechnology ETF (159892) with a net inflow of 185 million yuan [3] - Morgan Stanley S&P Hong Kong Low Volatility Dividend ETF (513630) with a net inflow of 179 million yuan [3] Outflow Details - The top outflow ETFs included: - Huatai-PineBridge Southbound Hang Seng Technology (QDII-ETF) (513130) with a net outflow of 249 million yuan [4][5] - Invesco CSI Hong Kong Stock Connect Central State-Owned Enterprises Dividend ETF (520990) with a net outflow of 65 million yuan [5] - E Fund Hang Seng State-Owned Enterprises ETF (510900) with a net outflow of 53 million yuan [5]

Summary of Key Points Core Viewpoint - On September 10, the total net inflow of cross-border ETFs reached 1.654 billion yuan, with a cumulative net inflow of 12.134 billion yuan over the past five trading days, indicating strong investor interest in these funds [1]. Fund Inflows - A total of 34 cross-border ETFs experienced net inflows on September 10, with the E Fund CSI Hong Kong Securities Investment ETF (513090) leading the inflow, increasing by 17.5 million shares and a net inflow of 407 million yuan [1][3]. - Other notable ETFs with significant inflows include: - Hua Bao CSI Hong Kong Stock Connect Internet ETF (513770) with a net inflow of 276 million yuan [3]. - E Fund Hang Seng Technology (QDII-ETF) (513010) with a net inflow of 170 million yuan [3]. Fund Outflows - On the same day, 17 cross-border ETFs recorded net outflows, with the Huatai-PB Korea Semiconductor ETF (QDII) (513310) showing the largest outflow, decreasing by 22 million shares and a net outflow of 42.67 million yuan [1][4]. - Other ETFs with notable outflows include: - Hua An Hang Seng Stock Connect Technology Theme ETF with a net outflow of 26 million yuan [5]. - Penghua CSI Hong Kong Stock Connect Medical and Health Comprehensive Trading ETF with a net outflow of 11 million yuan [5]. Performance Overview - The performance of the top inflow ETF, E Fund CSI Hong Kong Securities Investment ETF, showed a 1.00% increase, while the top outflow ETF, Huatai-PB Korea Semiconductor ETF, increased by 2.54% despite the outflow [3][5]. - The overall trend indicates a mixed performance among the ETFs, with some gaining traction while others faced withdrawals [1][4].

Group 1 - The article provides a ranking of the top 10 open-end funds based on net asset value growth as of August 21, 2025, highlighting the performance of various funds [2][4][7] - The top-performing fund is "汇添富双鑫添利债券D" with a net value of 1.2019, showing a significant increase from 1.0000 [2] - The bottom-performing fund is "前海开源周期精选混合C," which has a net value of 1.0343, down from 1.0816 [4][7] Group 2 - The article notes that a total of 28,402 funds have updated their net values, indicating a broad market activity [3] - The sectors leading the market include multi-financial and telecommunications, both showing gains of over 2% [7] - The article mentions that the "万家中证港股通创新药ETF" has experienced rapid net value growth, indicating strong performance in the healthcare sector [7] Group 3 - The article discusses the concentration of holdings in the top funds, with "万家中证港股通创新药ETF" having a concentration of 67.67% in its top ten holdings, primarily in the pharmaceutical sector [8] - The top holdings in this fund include "信达生物" and "药明生物," which have shown significant daily increases [8] - Conversely, the "前海开源周期精选混合C" fund has a lower concentration of 58.34% in its top holdings, with notable declines in some of its key stocks [8]

Group 1 - The core point of the news is the launch of the Huaan Hang Seng Hong Kong Stock Connect Technology Theme ETF, which will be listed on August 25, 2025, with a total of 1.453 billion shares [1] - As of August 18, 2025, the fund's asset allocation shows that bank deposits and settlement reserves account for 84.72% of total assets, while stock investments account for 15.26% [1] - The fund is currently in the accumulation phase, with a low average position of 24.50% among 18 newly announced stock ETFs in August [1][2] Group 2 - The Huaan Hang Seng Hong Kong Stock Connect Technology Theme ETF has the largest trading share among newly listed ETFs at 1.453 billion shares, followed by the Jiashi Zhongzheng Hong Kong Stock Connect Innovative Drug ETF with 890 million shares [2] - Institutional investors hold an average of 19.31% of the shares in the newly announced ETFs, with the highest proportions in the Huaxia Zhongzheng Hong Kong Stock Connect Medical Theme ETF at 95.41% and the Jiashi Hang Seng Hong Kong Stock Connect Technology Theme ETF at 83.60% [2] - The fund's stock position is expected to increase before the official listing date, as ETFs typically need to meet position requirements outlined in their fund contracts [1]

Core Viewpoint - Two stock ETFs have announced their listing, with the highest stock allocation being 54.18% for the Jiashi Hang Seng Hong Kong Stock Connect Technology Theme ETF [1] Group 1: ETF Listings and Allocations - As of August, a total of 14 stock ETFs have announced their listings, with an average allocation of 28.06% [1] - The Jiashi Hang Seng Hong Kong Stock Connect Technology Theme ETF has the highest allocation at 54.18%, followed by the Sci-Tech 200 ETF at 52.40%, the Penghua National Robot Industry ETF at 45.43%, and the Huatai-PineBridge National Internet ETF at 37.46% [1] - The lowest allocations are seen in the Industrial Bank Sci-Tech Value ETF and the Sci-Tech 50 ETF, both at 0.00%, and the Jiashi CSI Hong Kong Stock Connect Innovative Drug ETF at 16.11% [1] Group 2: Fundraising and Share Statistics - The average fundraising for the ETFs listed in August is 4.02 million shares, with the Jiashi CSI Hong Kong Stock Connect Innovative Drug ETF leading at 8.90 million shares, followed by the Sci-Tech 50 ETF at 7.54 million shares and the Sci-Tech 200 ETF at 6.17 million shares [1][2] - The Jiashi Hang Seng Consumption ETF has a fundraising size of 2.21 million shares with an allocation of 16.34% [2] - The Jiashi Hang Seng Hong Kong Stock Connect Technology Theme ETF has a fundraising size of 2.48 million shares with an allocation of 54.18% [2]

Summary of Key Points Core Viewpoint - On August 13, the total net inflow of cross-border ETFs reached 906 million yuan, with a cumulative net inflow of 20.62 billion yuan over the past five trading days, indicating strong investor interest in these funds [1]. Fund Inflows - A total of 40 cross-border ETFs experienced net inflows on August 13, with the top performer being the GF CSI Hong Kong Stock Connect Non-Bank ETF (513750), which saw an increase of 528 million shares and a net inflow of 906 million yuan [1][3]. - The GF CSI Hong Kong Stock Connect Non-Bank ETF had a latest scale of 14.879 billion yuan, reflecting a 1.78% increase in value [3]. Fund Outflows - Conversely, 50 cross-border ETFs recorded net outflows on the same day, with the leading outflow being the E Fund China Concept Internet 50 ETF (513050), which saw a reduction of 309 million shares and a net outflow of 454 million yuan [4][5]. - The E Fund China Concept Internet 50 ETF had a latest scale of 33.942 billion yuan, with a 4.06% increase in value despite the outflow [5]. Performance Overview - The top 10 ETFs by net inflow included several funds focused on technology and healthcare sectors, indicating a trend towards these industries among investors [3][5]. - The top 10 ETFs by net outflow highlighted a mix of technology and healthcare funds, suggesting a potential shift in investor sentiment or profit-taking in these areas [4][5].

Core Insights - Three stock ETFs have recently published listing announcements, with varying stock positions: Huaxia CSI A500 Enhanced Strategy ETF at 30.86%, Huatai-PineBridge CSI Hong Kong Internet ETF at 37.46%, and Industrial Bank Sci-Tech Price ETF at 0.00% [1][2] - Since August, a total of 12 stock ETFs have announced listings, with an average position of 26.86%. The highest position is held by Sci-Tech 200 ETF at 52.40% [1][2] - The average fundraising for the newly announced ETFs is 430 million shares, with the largest being Harvest CSI Hong Kong Innovative Medicine ETF at 890 million shares [1][2] ETF Positioning - The ETFs with the highest stock positions include: - Sci-Tech 200 ETF at 52.40% - Penghua CSI Robot Industry ETF at 45.43% - Huatai-PineBridge CSI Hong Kong Internet ETF at 37.46% - Harvest CSI Hong Kong Cloud Computing Industry ETF at 35.63% [1][2] - The ETFs with the lowest stock positions are: - Industrial Bank Sci-Tech Price ETF at 0.00% - Sci-Tech 50 ETF at 0.00% - Harvest CSI Hong Kong Innovative Medicine ETF at 16.11% [1][2] Institutional Investor Holdings - The average proportion of shares held by institutional investors is 18.92%, with the highest being: - Huaxia CSI Hong Kong Medical Theme ETF at 95.41% - Fuguo CSI Hong Kong High Dividend Investment ETF at 65.21% - Penghua Hang Seng ETF at 14.09% [2] - The ETFs with the lowest institutional investor holdings include: - Harvest CSI Hong Kong Innovative Medicine ETF at 2.13% - Sci-Tech 50 ETF at 2.28% - Sci-Tech 200 ETF at 4.47% [2]